Transcriptome analysis reveals the anti-Parkinson's activity of Mangiferin in zebrafish

As the global population ages, the incidence of Parkinson's Disease (PD) continues to rise, imposing significant social and economic burdens. Mangiferin (MGF), a polyphenolic, bioactive compound has been shown to play a role in the prevention and treatment of PD. This study investigates the neu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicine & pharmacotherapy 2024-10, Vol.179, p.117387, Article 117387
Hauptverfasser: Qin, Fengqing, Zhang, Ming, Wang, Pei, Dai, Ziru, Li, Xi, Li, Dongliang, Jing, Lijun, Qi, Cen, Fan, Heliang, Qin, Mei, Li, Ying, Huang, Likun, Wang, Tianci
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 117387
container_title Biomedicine & pharmacotherapy
container_volume 179
creator Qin, Fengqing
Zhang, Ming
Wang, Pei
Dai, Ziru
Li, Xi
Li, Dongliang
Jing, Lijun
Qi, Cen
Fan, Heliang
Qin, Mei
Li, Ying
Huang, Likun
Wang, Tianci
description As the global population ages, the incidence of Parkinson's Disease (PD) continues to rise, imposing significant social and economic burdens. Mangiferin (MGF), a polyphenolic, bioactive compound has been shown to play a role in the prevention and treatment of PD. This study investigates the neuroprotective effects of MGF in an MPTP-induced zebrafish model of PD through transcriptome analysis. Initially, optimal concentrations for modeling were determined using various MPTP and MGF combinations. The zebrafish were then divided into control, MPTP-treated, and MGF co-treated groups. Subsequent evaluations included hatching rates, mortality rates, growth and development conditions, spontaneous motor abilities, as well as measurements of enzymatic activities of SOD, CAT, and levels of GSH. Ultimately, the therapeutic efficacy of MGF on the PD model in zebrafish was assessed through transcriptome sequencing. The results demonstrated that MPTP treatment induced PD-associated symptoms in zebrafish, while MGF treatment significantly improved the motor abilities and survival rates of the PD model zebrafish, effectively reducing oxidative stress and ameliorating PD symptoms. Transcriptome sequencing further revealed that MGF may mitigate mitochondrial-related oxidative stress in PD zebrafish by modulating the expression of critical genes including lrrk2, vps35, atp13a, dnajc6, and uchl1. Differential gene expression analysis indicated that these genes are primarily involved in vital signaling pathways, such as neuroactive ligand-receptor interaction, and the calcium signaling pathway. In summary, our study provides robust scientific evidence supporting MGF as a potential therapeutic candidate for PD by preserving mitochondrial homeostasis and elucidating its mechanisms of action. [Display omitted] •Mangiferin can alleviate MPTP-induced symptoms in zebrafish PD.•Mangiferin regulates PD-related genes such as lrrk2, vps35, atp13a, dnajc6, and uchl1.•Mangiferin can inhibit mitochondrial oxidative stress induced by MPTP.
doi_str_mv 10.1016/j.biopha.2024.117387
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3102070728</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0753332224012721</els_id><sourcerecordid>3102070728</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-79670f2117a8d0f9760015eb4f29f38d79512265934ddd29cc7c457a7ea91bc93</originalsourceid><addsrcrecordid>eNp9kE9Lw0AQxRdRbK1-A5Hc9JI6u5tksxdBiv-gooeKx2WzmbVb2yTupoX66U1J9SgMDAzvzbz5EXJOYUyBZteLceHqZq7HDFgyplTwXByQIZUpxBmAOCRDECmPOWdsQE5CWABAmvH8mAy4ZEkKwIbkfeZ1FYx3TVuvMNKVXm6DC5HHDepliNr5bti6-FX7T1eFuroMkTat27h2G9U2etbVh7PoXRV19Y2F19aF-Sk5sp0fz_Z9RN7u72aTx3j68vA0uZ3GhlPaxkJmAizr0uu8BCtFl5ymWCSWScvzUsiUMpalkidlWTJpjDBJKrRALWlhJB-Rq35v4-uvNYZWrVwwuFzqCut1UJwCAwGC5Z006aXG1yF4tKrxbqX9VlFQO6RqoXqkaodU9Ug728X-wrpYYfln-mXYCW56AXZ_bhx6FYzDymDpPJpWlbX7_8IPh4WJPg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3102070728</pqid></control><display><type>article</type><title>Transcriptome analysis reveals the anti-Parkinson's activity of Mangiferin in zebrafish</title><source>Elsevier ScienceDirect Journals Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Qin, Fengqing ; Zhang, Ming ; Wang, Pei ; Dai, Ziru ; Li, Xi ; Li, Dongliang ; Jing, Lijun ; Qi, Cen ; Fan, Heliang ; Qin, Mei ; Li, Ying ; Huang, Likun ; Wang, Tianci</creator><creatorcontrib>Qin, Fengqing ; Zhang, Ming ; Wang, Pei ; Dai, Ziru ; Li, Xi ; Li, Dongliang ; Jing, Lijun ; Qi, Cen ; Fan, Heliang ; Qin, Mei ; Li, Ying ; Huang, Likun ; Wang, Tianci</creatorcontrib><description>As the global population ages, the incidence of Parkinson's Disease (PD) continues to rise, imposing significant social and economic burdens. Mangiferin (MGF), a polyphenolic, bioactive compound has been shown to play a role in the prevention and treatment of PD. This study investigates the neuroprotective effects of MGF in an MPTP-induced zebrafish model of PD through transcriptome analysis. Initially, optimal concentrations for modeling were determined using various MPTP and MGF combinations. The zebrafish were then divided into control, MPTP-treated, and MGF co-treated groups. Subsequent evaluations included hatching rates, mortality rates, growth and development conditions, spontaneous motor abilities, as well as measurements of enzymatic activities of SOD, CAT, and levels of GSH. Ultimately, the therapeutic efficacy of MGF on the PD model in zebrafish was assessed through transcriptome sequencing. The results demonstrated that MPTP treatment induced PD-associated symptoms in zebrafish, while MGF treatment significantly improved the motor abilities and survival rates of the PD model zebrafish, effectively reducing oxidative stress and ameliorating PD symptoms. Transcriptome sequencing further revealed that MGF may mitigate mitochondrial-related oxidative stress in PD zebrafish by modulating the expression of critical genes including lrrk2, vps35, atp13a, dnajc6, and uchl1. Differential gene expression analysis indicated that these genes are primarily involved in vital signaling pathways, such as neuroactive ligand-receptor interaction, and the calcium signaling pathway. In summary, our study provides robust scientific evidence supporting MGF as a potential therapeutic candidate for PD by preserving mitochondrial homeostasis and elucidating its mechanisms of action. [Display omitted] •Mangiferin can alleviate MPTP-induced symptoms in zebrafish PD.•Mangiferin regulates PD-related genes such as lrrk2, vps35, atp13a, dnajc6, and uchl1.•Mangiferin can inhibit mitochondrial oxidative stress induced by MPTP.</description><identifier>ISSN: 0753-3322</identifier><identifier>ISSN: 1950-6007</identifier><identifier>EISSN: 1950-6007</identifier><identifier>DOI: 10.1016/j.biopha.2024.117387</identifier><identifier>PMID: 39245002</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Mangiferin ; Oxidative stress ; Parkinson's disease ; Transcriptome sequencing ; Zebrafish</subject><ispartof>Biomedicine &amp; pharmacotherapy, 2024-10, Vol.179, p.117387, Article 117387</ispartof><rights>2024 The Authors</rights><rights>Copyright © 2024. Published by Elsevier Masson SAS.</rights><rights>Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c311t-79670f2117a8d0f9760015eb4f29f38d79512265934ddd29cc7c457a7ea91bc93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0753332224012721$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39245002$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Qin, Fengqing</creatorcontrib><creatorcontrib>Zhang, Ming</creatorcontrib><creatorcontrib>Wang, Pei</creatorcontrib><creatorcontrib>Dai, Ziru</creatorcontrib><creatorcontrib>Li, Xi</creatorcontrib><creatorcontrib>Li, Dongliang</creatorcontrib><creatorcontrib>Jing, Lijun</creatorcontrib><creatorcontrib>Qi, Cen</creatorcontrib><creatorcontrib>Fan, Heliang</creatorcontrib><creatorcontrib>Qin, Mei</creatorcontrib><creatorcontrib>Li, Ying</creatorcontrib><creatorcontrib>Huang, Likun</creatorcontrib><creatorcontrib>Wang, Tianci</creatorcontrib><title>Transcriptome analysis reveals the anti-Parkinson's activity of Mangiferin in zebrafish</title><title>Biomedicine &amp; pharmacotherapy</title><addtitle>Biomed Pharmacother</addtitle><description>As the global population ages, the incidence of Parkinson's Disease (PD) continues to rise, imposing significant social and economic burdens. Mangiferin (MGF), a polyphenolic, bioactive compound has been shown to play a role in the prevention and treatment of PD. This study investigates the neuroprotective effects of MGF in an MPTP-induced zebrafish model of PD through transcriptome analysis. Initially, optimal concentrations for modeling were determined using various MPTP and MGF combinations. The zebrafish were then divided into control, MPTP-treated, and MGF co-treated groups. Subsequent evaluations included hatching rates, mortality rates, growth and development conditions, spontaneous motor abilities, as well as measurements of enzymatic activities of SOD, CAT, and levels of GSH. Ultimately, the therapeutic efficacy of MGF on the PD model in zebrafish was assessed through transcriptome sequencing. The results demonstrated that MPTP treatment induced PD-associated symptoms in zebrafish, while MGF treatment significantly improved the motor abilities and survival rates of the PD model zebrafish, effectively reducing oxidative stress and ameliorating PD symptoms. Transcriptome sequencing further revealed that MGF may mitigate mitochondrial-related oxidative stress in PD zebrafish by modulating the expression of critical genes including lrrk2, vps35, atp13a, dnajc6, and uchl1. Differential gene expression analysis indicated that these genes are primarily involved in vital signaling pathways, such as neuroactive ligand-receptor interaction, and the calcium signaling pathway. In summary, our study provides robust scientific evidence supporting MGF as a potential therapeutic candidate for PD by preserving mitochondrial homeostasis and elucidating its mechanisms of action. [Display omitted] •Mangiferin can alleviate MPTP-induced symptoms in zebrafish PD.•Mangiferin regulates PD-related genes such as lrrk2, vps35, atp13a, dnajc6, and uchl1.•Mangiferin can inhibit mitochondrial oxidative stress induced by MPTP.</description><subject>Mangiferin</subject><subject>Oxidative stress</subject><subject>Parkinson's disease</subject><subject>Transcriptome sequencing</subject><subject>Zebrafish</subject><issn>0753-3322</issn><issn>1950-6007</issn><issn>1950-6007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kE9Lw0AQxRdRbK1-A5Hc9JI6u5tksxdBiv-gooeKx2WzmbVb2yTupoX66U1J9SgMDAzvzbz5EXJOYUyBZteLceHqZq7HDFgyplTwXByQIZUpxBmAOCRDECmPOWdsQE5CWABAmvH8mAy4ZEkKwIbkfeZ1FYx3TVuvMNKVXm6DC5HHDepliNr5bti6-FX7T1eFuroMkTat27h2G9U2etbVh7PoXRV19Y2F19aF-Sk5sp0fz_Z9RN7u72aTx3j68vA0uZ3GhlPaxkJmAizr0uu8BCtFl5ymWCSWScvzUsiUMpalkidlWTJpjDBJKrRALWlhJB-Rq35v4-uvNYZWrVwwuFzqCut1UJwCAwGC5Z006aXG1yF4tKrxbqX9VlFQO6RqoXqkaodU9Ug728X-wrpYYfln-mXYCW56AXZ_bhx6FYzDymDpPJpWlbX7_8IPh4WJPg</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Qin, Fengqing</creator><creator>Zhang, Ming</creator><creator>Wang, Pei</creator><creator>Dai, Ziru</creator><creator>Li, Xi</creator><creator>Li, Dongliang</creator><creator>Jing, Lijun</creator><creator>Qi, Cen</creator><creator>Fan, Heliang</creator><creator>Qin, Mei</creator><creator>Li, Ying</creator><creator>Huang, Likun</creator><creator>Wang, Tianci</creator><general>Elsevier Masson SAS</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20241001</creationdate><title>Transcriptome analysis reveals the anti-Parkinson's activity of Mangiferin in zebrafish</title><author>Qin, Fengqing ; Zhang, Ming ; Wang, Pei ; Dai, Ziru ; Li, Xi ; Li, Dongliang ; Jing, Lijun ; Qi, Cen ; Fan, Heliang ; Qin, Mei ; Li, Ying ; Huang, Likun ; Wang, Tianci</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-79670f2117a8d0f9760015eb4f29f38d79512265934ddd29cc7c457a7ea91bc93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Mangiferin</topic><topic>Oxidative stress</topic><topic>Parkinson's disease</topic><topic>Transcriptome sequencing</topic><topic>Zebrafish</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Qin, Fengqing</creatorcontrib><creatorcontrib>Zhang, Ming</creatorcontrib><creatorcontrib>Wang, Pei</creatorcontrib><creatorcontrib>Dai, Ziru</creatorcontrib><creatorcontrib>Li, Xi</creatorcontrib><creatorcontrib>Li, Dongliang</creatorcontrib><creatorcontrib>Jing, Lijun</creatorcontrib><creatorcontrib>Qi, Cen</creatorcontrib><creatorcontrib>Fan, Heliang</creatorcontrib><creatorcontrib>Qin, Mei</creatorcontrib><creatorcontrib>Li, Ying</creatorcontrib><creatorcontrib>Huang, Likun</creatorcontrib><creatorcontrib>Wang, Tianci</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedicine &amp; pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Qin, Fengqing</au><au>Zhang, Ming</au><au>Wang, Pei</au><au>Dai, Ziru</au><au>Li, Xi</au><au>Li, Dongliang</au><au>Jing, Lijun</au><au>Qi, Cen</au><au>Fan, Heliang</au><au>Qin, Mei</au><au>Li, Ying</au><au>Huang, Likun</au><au>Wang, Tianci</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transcriptome analysis reveals the anti-Parkinson's activity of Mangiferin in zebrafish</atitle><jtitle>Biomedicine &amp; pharmacotherapy</jtitle><addtitle>Biomed Pharmacother</addtitle><date>2024-10-01</date><risdate>2024</risdate><volume>179</volume><spage>117387</spage><pages>117387-</pages><artnum>117387</artnum><issn>0753-3322</issn><issn>1950-6007</issn><eissn>1950-6007</eissn><abstract>As the global population ages, the incidence of Parkinson's Disease (PD) continues to rise, imposing significant social and economic burdens. Mangiferin (MGF), a polyphenolic, bioactive compound has been shown to play a role in the prevention and treatment of PD. This study investigates the neuroprotective effects of MGF in an MPTP-induced zebrafish model of PD through transcriptome analysis. Initially, optimal concentrations for modeling were determined using various MPTP and MGF combinations. The zebrafish were then divided into control, MPTP-treated, and MGF co-treated groups. Subsequent evaluations included hatching rates, mortality rates, growth and development conditions, spontaneous motor abilities, as well as measurements of enzymatic activities of SOD, CAT, and levels of GSH. Ultimately, the therapeutic efficacy of MGF on the PD model in zebrafish was assessed through transcriptome sequencing. The results demonstrated that MPTP treatment induced PD-associated symptoms in zebrafish, while MGF treatment significantly improved the motor abilities and survival rates of the PD model zebrafish, effectively reducing oxidative stress and ameliorating PD symptoms. Transcriptome sequencing further revealed that MGF may mitigate mitochondrial-related oxidative stress in PD zebrafish by modulating the expression of critical genes including lrrk2, vps35, atp13a, dnajc6, and uchl1. Differential gene expression analysis indicated that these genes are primarily involved in vital signaling pathways, such as neuroactive ligand-receptor interaction, and the calcium signaling pathway. In summary, our study provides robust scientific evidence supporting MGF as a potential therapeutic candidate for PD by preserving mitochondrial homeostasis and elucidating its mechanisms of action. [Display omitted] •Mangiferin can alleviate MPTP-induced symptoms in zebrafish PD.•Mangiferin regulates PD-related genes such as lrrk2, vps35, atp13a, dnajc6, and uchl1.•Mangiferin can inhibit mitochondrial oxidative stress induced by MPTP.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>39245002</pmid><doi>10.1016/j.biopha.2024.117387</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0753-3322
ispartof Biomedicine & pharmacotherapy, 2024-10, Vol.179, p.117387, Article 117387
issn 0753-3322
1950-6007
1950-6007
language eng
recordid cdi_proquest_miscellaneous_3102070728
source Elsevier ScienceDirect Journals Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Mangiferin
Oxidative stress
Parkinson's disease
Transcriptome sequencing
Zebrafish
title Transcriptome analysis reveals the anti-Parkinson's activity of Mangiferin in zebrafish
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A03%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transcriptome%20analysis%20reveals%20the%20anti-Parkinson's%20activity%20of%20Mangiferin%20in%20zebrafish&rft.jtitle=Biomedicine%20&%20pharmacotherapy&rft.au=Qin,%20Fengqing&rft.date=2024-10-01&rft.volume=179&rft.spage=117387&rft.pages=117387-&rft.artnum=117387&rft.issn=0753-3322&rft.eissn=1950-6007&rft_id=info:doi/10.1016/j.biopha.2024.117387&rft_dat=%3Cproquest_cross%3E3102070728%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3102070728&rft_id=info:pmid/39245002&rft_els_id=S0753332224012721&rfr_iscdi=true